The mouse Peg1/Mest gene is an imprinted gene that is expressed particularly in mesodermal tissues in early embryonic stages. It was the most abundant imprinted gene among eight paternally expressed genes (Peg 1-8) isolated by a subtraction-hybridization method from a mouse embryonal cDNA library. It has been mapped to proximal mouse chromosome 6, maternal duplication of which causes early embryonic lethality. The human chromosomal region that shares syntenic homology with this is 7q21-qter, and human maternal uniparental disomy 7 (UPD 7) causes apparent growth deficiency and slight morphological abnormalities. Therefore, at least one paternally expressed imprinted gene seems to be present in this region. In this report, we demonstrate that human PEG1/MEST is an imprinted gene expressed from a paternal allele and located on chromosome 7q31-34, near D7S649. It is the first imprinted gene mapped to human chromosome 7 and a candidate for a gene responsible for primordial growth retardation including Silver-Russell syndrome (SRS).
INTRODUCTION
Genomic imprinting influences mammalian development, growth and behavior (1) (2) (3) , and some human genetic diseases and cancers have been attributed to genomic imprinting (4, 5) . Genes that are expressed from only the maternal or paternal genome are thought to play essential roles in these phenomena. Therefore, isolation of novel imprinted genes is important for identifying genes that cause human diseases and for clarifying the molecular mechanisms of these diseases. Although >10 imprinted genes have been reported to date, many are yet to be identified. Recently, we developed a novel subtraction-hybridization method to isolate imprinted genes systematically and obtained eight paternally expressed genes (Peg1-8) (6) (7) (8) including two known imprinted genes, Igf2 and Snrpn (9) (10) (11) , from an 8.5 day mouse embryonal cDNA library.
Among these Pegs, Peg1 was expressed most abundantly in early embryos and showed identity to the 121a (Mest; mesodermspecific transcript) gene that is expressed specifically in mesodermal tissues (12, 13) . Mouse parthenogenetic embryos cannot survive beyond day 10 of gestation which is when Peg1/Mest is expressed most abundantly (N. Miyoshi et al., unpublished data). Peg1/Mest was mapped to the proximal region of mouse chromosome 6 (12) . Mice that have maternal duplication of this region with a Robertsonian translocation show early embryonic lethality (2, 3) . These results suggest that Peg1/Mest is a candidate for a gene involved in embryonic lethality.
The proximal region of mouse chromosome 6 shares syntenic homology with human chromosome 7q21-qter (14) . Human maternal uniparental disomy 7 (UPD 7), similar to the homologous region in mouse, shows some imprinting effect (15) (16) (17) (18) (19) (20) . To date, human maternal UPD of the whole of chromosome 7 has been reported in eight patients with intrauterine and postnatal growth retardation with slight morphological abnormalities (16) (17) (18) (19) (20) . Three cases were found in patients that were homozygous for known recessive mutations, two cases with CF (cystic fibrosis) (16, 17) and one case with COL1A2 [proα2(I) chain of type I procollagen] (18). Recently, Kotzot et al. investigated 35 patients that showed primordial growth retardation, including sporadic Silver-Russell syndrome (SRS) and their parents, with microsatellite markers and found four cases of UPD 7 (20) . Another case involved a child with maternal heterodisomy of chromosome 7. A trisomy with two maternal and one paternal chromosome 7 was observed in placental cells during the fetal stage, and a subsequent loss of paternal chromosome 7 seemed to occur in embryonal cells (19) . All these patients showed both prenatal and postnatal growth retardation with frequent morphological abnormalities. One case with uniparental isodisomy for paternal 7p and maternal 7q also showed postnatal growth retardation and morphological abnormalities (21) . Therefore, it is *To whom correspondence should be addressed. Tel: +81 45 924 5812; Fax: +81 45 924 5814; Email: fishino@bio.titech.ac.jp probable that loss of paternally expressed gene(s) on human chromosome 7 causes these defects. Human PEG1/MEST is a candidate for such a gene if it is proved to be imprinted and located on chromosome 7.
RESULTS

Comparison of human PEG1/MEST and mouse
Peg1/Mest
Human PEG1/MEST was isolated from a fetal kidney cDNA library using a mouse Peg1/Mest DNA fragment as a probe (see Materials and Methods). Nine clones were isolated, and further analysis was carried out on eight clones. Of the eight clones, seven had a 2.5 kb insert and one had a 1.6 kb insert ( Fig. 1a and  b) . Recently, the human MEST gene was independently isolated and analyzed by Nishita et al. The result of the nucleotide sequence of the 2.5 kb transcript is almost the same as ours (22) . The short transcript used a different poly(A) site (1558 bp), as shown in Figure 1 . The human PEG1/MEST gene seemed to have the same reading frame (from the ATG codon at 223 bp to 1230 bp in the 2.5 kb transcript) as the mouse Peg1/Mest gene. However, we could not find this ATG in two of the clones. There was a single base pair deletion at 249 bp in one clone and the transcript had a different reading frame from the PEG1/MEST protein and stops immediately after the initiation codon. In the short transcript (Fig. 1b) there was a small deletion (23 bp) including the first ATG at 223 bp. Although it is possible that these clones represent cloning artifacts, we speculate that the second ATG codon at 250 bp may function as an initiation codon.
It will be necessary to analyze the N-terminal amino acid sequences of the PEG1/MEST protein to identify the precise reading frame.
The nucleic acid sequence of the reading frame of PEG1/MEST is highly conserved between human and mouse (90.7%), while homology in the 5′-untranslated region (UTR) and 3′ UTR are relatively low (67 and 59%, respectively), provided that the reading frame of human PEG1/MEST starts from the first ATG codon (223 bp) as described above. Human PEG1/MEST protein has all the sequence motifs (RVIAPD motif, GxGxS motif, nucleophile motif, catalytic Asp and His; Fig. 1 ) observed in the α/β hydrolase fold family as well as in mouse Peg1/Mest protein (6, 23, 24) . The total number of amino acids in the PEG1/MEST protein from these two species is the same (335 amino acids) and almost all the amino acids (326/335) are conserved. The amino acids in the sequence motifs of this class of enzymes are completely conserved.
Imprinting of human PEG1/MEST
Expression of mouse Peg1/Mest was high in early embryonic stages but decreased considerably in late embryonic and neonatal stages (N. Miyoshi et al., unpublished data). Relatively early stage human embryos (6-9 weeks of gestation) were selected to analyze the expression and imprinting status of human PEG1/MEST. To assign the parental origin of the expressed allele, genomic DNA from 19 embryonal samples and peripheral blood from their parents were analyzed and five families informative for a DNA polymorphism at an AflIII site (1922 bp in Fig. 1 ) were identified. Imprinting of human PEG1/MEST was examined in these five families using the PEG1/MEST DNA polymorphism ( Fig. 2A) . Two types of pattern, 'a' and 'b' (uncut and cut following AflIII digestion) were observed. RT-PCR analysis was carried out on both embryos and chorions. The expression level of PEG1/MEST in the chorions was about one-thirtieth of that in the embryos. The result obtained from samples 3, 4 and 5 in Table  1 is shown in Figure 2B , C and D, respectively. For example, in Figure 2B , the patterns of the PEG1/MEST DNA polymorphism in genomic DNA from the mother, father, embryo and chorion were 'a', 'a/b', 'a/b' and 'a/b', respectively. The expressed allele showed the 'b' pattern in the latter two samples and was apparently derived from the father. All samples except one embryo (Table 1 , sample No.1*) showed monoallelic expression, and paternal expression of human PEG1/MEST was confirmed in four families (the chromosome from which the gene was expressed could not be distinguished in sample No. 4) ( Table 1) . Analysis of a human PEG3 DNA polymorphism (T. Kohda et al., unpublished data) indicated that a large amount of maternal tissues was contained in the embryonic sample that showed biallelic expression (Table 1 , sample No.1*). Pathological examination also verified that a large part of the sample consisted of maternal undeveloped decidual tissues. The paternal express-ion pattern 'b' was confirmed in the corresponding chorion. RT-PCR analysis showed expression pattern 'a' in the maternal decidual tissues (data not shown). These data supported the theory that the apparent biallelic expression pattern of this embryonic sample was derived from both the embryo and the maternal tissues. These results demonstrated that human PEG1/MEST is paternally expressed in both embryos and chorions in early development. It should be noted that maternal allele expression less than one-twentieth of that observed from the paternal allele was observed in every sample (Fig. 2B-D, lanes  5 and 8) . The possibility of maternal tissue contamination in these samples was checked by using WT1 DNA polymorphism (25) . The data confirmed that there were no signals of maternal tissue in the samples of B and C in Figure 2 and these samples were free from maternal tissue at the level of sensitivity of PCR (data not shown), suggesting that there is the leaky expression from the maternal allele in the human PEG1/MEST. Almost no maternal expression of Peg1/Mest was detected at the same developmental stages in the mouse (6) .
Mapping of the PEG1/MEST gene using YAC clones
In order to map the PEG1/MEST gene, we have identified four independent YAC clones (805e8, 858e9, 920e1, 973d7) containing the (26) . The four PEG1/MESTpositive clones were tested to determine whether both PEG1/MEST and D7S649 could be detected in the same clone by PCR assays. PEG1/MEST and D7S649 were detected simultaneously in all four YAC clones (Fig. 3A) . The D7S649 marker is located between D7S530 and D7S500 (27) and these two markers have been mapped cytogenetically to 7q31-32 and 7q31-34, respectively (28) . Thus, we concluded that human PEG1/MEST maps to 7q31-34 and is located near D7S649, probably within ∼1 Mb, taking into consideration the insert size of the YAC library (Fig. 3B) .
DISCUSSION
Human PEG1/MEST is highly homologous to mouse Peg1/Mest and encodes a similar protein that belongs to the α/β hydrolase fold family. Because the catalytic specificities of this class of enzymes are radically different, including haloalkans, lipids and epoxides (24) , it is very difficult to propose a substrate for the PEG1/MEST protein. Therefore, the biological function of PEG1/MEST remains unclear. In the mouse, parthenogenetic cells that do not express any paternally expressed genes, including Peg1/Mest, were segregated out from mesodermal tissues in normal×parthenogenetic chimeras (29, 30) . Lack of paternally expressed gene(s) must be involved in this phenomenon. To date, Peg1/Mest, Igf2 and Peg3 are the candidate imprinted genes that show mesodermal-specific expression in early development. Thus, it is possible that the PEG1/MEST protein metabolizes some biological substance that affects the growth and maintenance of mesodermal cells via its hydrolase activity. Not only the two mammalian species mentioned above but also a variety of other animals, including the African green monkey (Cercopithecus aethiops), marsupial rat (Dasyuroides byrnei byrnei), goldfish (Carrassius auratus) and fruit fly (Drosophila melanogaster) seem to have genes homologous to Peg1/Mest on zoo blot analysis (12) . Therefore, PEG1/MEST is evolutionally conserved in higher animals and this may point to the functional importance of PEG1/MEST protein in embryonic development. Analysis of Peg1/Mest knockout mice will shed light on its role in early mammalian development.
Human PEG1/MEST was also proved to be imprinted and paternally expressed in this study. Nishita et al. (22) recently reported that human MEST gene was expressed at much higher levels in hydatidiform moles than in dermoide cysts and suggested that human MEST was imprinted. It is important to test for imprinting in the tissues that are physiologically relevant. However, it is not adequate for verification of PEG1/MEST imprinting to compare the expression levels in totally different two tissues (placentae and embryos). Moreover, it is known that expression of imprinted genes such as the H19 gene in the placentae of androgenetic embryos does not necessarily reflect the expression of normal placentae (31) . Thus, in order to prove the imprinted status of PEG1/MEST conclusively, it is necessary to analyze parental expression in the families directly. Figure 2A . Although we used whole embryo, the embryonal tissue could not be identified as coming from any specific organ due to the early stage termination. Figure 1 . PCR products were digested with AflIII and electrophoresed through a 2% agarose gel. ΦX174/HaeIII fragments were used as molecular weight makers (lane 1). The data confirms that the paternal allele was expressed in both the embryo and chorion. According to the genetic mapping data, D7S649 is located between D7S530 and D7S500. These two markers have been cytogenetically mapped to 7q31-32 and 7q31-34, respectively, indicating that human PEG1/MEST maps to the interval 7q31-34. The position of D7S649 on the genetic map is indicated by a box.
Chromosomal location of PEG1/MEST on 7q31-34 is homologous to the proximal region of mouse chromosome 6 where mouse Peg1/Mest was mapped. In the mouse, maternal duplication of this region causes early embryonic lethality. Maternal UPD 7 cases have been identified in some human patients that showed growth retardation and slight morphological abnormalities, including SRS. There are reports of both familial and sporadic cases of SRS and the syndrome appears to be heterogenous (32) (33) (34) (35) . Three different modes of inheritance have been seen in the familial cases, dominant mutation, autosomal recessive transmission and X-linked dominant inheritance. However, the genetic loci responsible for this syndrome remained unclear (32) . About 80% of SRS patients were thought to be sporadic cases (32) . Among these, there are two types that may provide us with clues about candidate genes responsible for this syndrome: (i) two cases of translocation of chromosome 17q25 (36, 37) and (ii) four cases of UPD 7 have been reported (20) . In the former case, the responsible gene may be located on chromosome 17q25 because the translocation break points were identical. In the latter cases, lack of paternally expressed gene(s) or/and overexpression of maternally expressed gene(s) (less likely) on chromosome 7 may trigger this syndrome as all UPD 7 were shown to be maternal disomies. Because human PEG1/MEST is the first imprinted gene to be identified on human chromosome 7, it is possible that this gene may be responsible for SRS. Chromosomal location on 7q31-34 is consistent with the report of Eggerding et al. that the patient with uniparental isodisomy for paternal 7p and maternal 7q also had features of SRS (21), although the precise location of the gene(s) responsible for SRS on chromosome 7 has not been determined. It will be of interest to examine partial UPDs or partial deletions in SRS patients around the region containing the PEG1/MEST gene. It is also important to note that identification of familial cases showing paternal inheritance of this syndrome would allow clarification of the involvement of PEG1/MEST in SRS because a mutation may occur in the paternal expressed imprinted gene responsible for SRS.
MATERIALS AND METHODS
Isolation of human PEG1/MEST
A human fetal kidney 5′-STRETCH cDNA library (#HL1150x CLONTECH; consisting of four male/female Caucasian fetuses, 20-26 weeks of gestation) was screened with a mouse Peg1/Mest cDNA which corresponds to bases 427-693 (MUS121A; GenBank accession no. D16262). Nine independent human PEG1/MEST cDNA clones were isolated by screening ∼9×10 4 plaques at a final stringency of 2× SSC containing 0.1% SDS at 65_C.
DNA sequencing
Several overlapping deletion clones were prepared using KiloSequence Deletion Kit (TaKaRa). Sequence was determined by the dideoxy method using the Auto Cycle sequencing Kit (Pharmacia) for the Automated Laser Fluorescent (ALF) sequencer.
Tissue samples
Human embryos and placentae were obtained from therapeutic terminations. Peripheral blood from the parents was also obtained.
PCR amplification of genomic DNA and expression analysis by RT-PCR
Genomic DNA and total RNA were prepared using ISOGEN (Nippon Gene) as described previously (6, 8) . For PCR analysis, 100 ng of genomic DNA in a 100 µl reaction mixture containing 1× ExTaq buffer (TaKaRa), 2.5 mM dNTP mixture, 80 pmol of primers and 2.5 U of ExTaq (TaKaRa) was subjected to 30 cycles of PCR. PCR was carried out on the Perkin Elmer GeneAmp PCR system 9600; 95_C for 30 s, 65_C for 30 s, 72_C for 60 s. The PEG1/MEST primers were 5′-CACTGATGCAGAAAG-ACGTTC-3′ (HP1F) and 5′-CAGCACCATTTGCTCATAGG-3′ (HP1R). For expression analysis by RT-PCR, 1 µg of total RNA from each sample was used to synthesize DNA using Superscript reverse transcriptase II (GibcoBRL) with oligo(dT) primer at 42_C for 50 min. Then one-thousandth of the resulting cDNA was subjected to PCR under the same conditions as genomic DNA.
YAC clones
Human YAC DNA library CEPH B (#95011B Research Genetics; CEPH library plate numbers 805-984) was screened using the PEG1/MEST primers under the same PCR condition as described above. Positive clones were purified on plates lacking uracil and tryptophan and tested by PCR of single colonies. A complete description of PCR primers and conditions for amplification of D7S649 is available from the Genome Data Base.
